SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-124360
Filing Date
2022-12-05
Accepted
2022-12-05 07:00:48
Documents
4
Period of Report
2022-12-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2231325-2_def14a.htm DEF 14A 376565
2 GRAPHIC lg_georgesonric-4c.jpg GRAPHIC 9474
3 GRAPHIC tm2231325d2-px_proxy14c.jpg GRAPHIC 899189
4 GRAPHIC tm2231325d2-px_proxy24c.jpg GRAPHIC 654035
  Complete submission text file 0001104659-22-124360.txt   2529974
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35737 | Film No.: 221443724
SIC: 2834 Pharmaceutical Preparations